Jannis Kountourasa, Christos Zavosa, Stergios A. Polyzosa, Georgia Deretzib
Aristotle University of Thessaloniki, Ippokration Hospital; Papageorgiou General Hospital, Thessaloniki, Macedonia, Greece
Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital (Jannis Kountouras, Christos Zavos, Stergios A. Polyzos); bDepartment of Neurology, Multiple Sclerosis Unit, Papageorgiou General Hospital (Georgia Deretzi), Thessaloniki, Macedonia, Greece
Kaltsa et al [1] reported that human β defensin-1 (hBD-1) is upregulated in cirrhotic patients and might serve as a biomarker of bacterial translocation involved in the pathogenesis of complications including hepatic encephalopathy (HE); dysbiosis of gastrointestinal microbiota, even salivary and gastric Helicobacter pylori (Hp) and multiple non-Hp organisms, is associated with systemic inflammation and complications including HE [1-3].
Hp infection (Hp-I), strongly associated with viral-related cirrhosis, is more common in cirrhotic patients with HE. Hp may be involved in HE and post-HE persistent cognitive dysfunction pathophysiology by releasing proinflammatory and vasoactive substances involved, through blood-brain barrier (BBB) disruption, in brain pathologies; Hp might access the brain via the oral-nasal-olfactory pathway or by circulating monocytes (infected with Hp due to defective autophagy) through disrupted BBB, leading to neurodegeneration [4-6]. Likewise, human defensins might also contribute to Hp-related brain pathophysiology by modulating innate and adaptive immune system responses [7].
Hp-I induces hBD-1 mRNA expression [8], but develops resistance against hBD-1 [9]. Moreover, Hp might be further involved in the BBB breakdown, by releasing defensins, particularly those that display unique distribution at BBB sites. Hp can activate granulocytes and induce defensin release from granulocytes; consequently, defensins, secreted by activated granulocytes, penetrate the BBB, gain access to the brain, thereby possibly contributing to neurodegeneration [9]. In the brain, HBD-1 expression acts as activator and modulator of innate and adaptive immunity within microglia and astrocytes, cerebral cells critical to the brain neuroinflammatory responses. HBD-1 mRNA expression is significantly increased in the choroid plexus and hippocampus of the neurodegenerative brain; HBD-1 might be of considerable importance early in the neurodegenerative process [9]. Finally, serum sCD14 levels, mentioned by the authors [1], are associated with genetic variants in both CD14 promoter and Hp-I and consequently with certain disease or diseases outcomes [10]. However, further studies are needed to elucidate the aforementioned considerations.
1. Kaltsa A, Bamias G, Siakavellas S, Systemic levels of human β-defensin 1 are elevated in patients with cirrhosisAnn Gastroenterol 2016; 29: 62-69.
2. Bajaj JS, Betrapally NS, Hylemon PB, Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathyHepatology 2015; 62: 1260-1271.
3. Sheh A, Fox JG, The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesisGut Microbes 2013; 4: 505-531.
4. Kountouras J, Polyzos SA, Deretzi G, Helicobacter pylori associated with obstructive sleep apnea might contribute to sleep, cognition, and driving performance disturbances in patients with cirrhosisClin Gastroenterol Hepatol 2015; 13: 1547
5. Kountouras J, Zavos C, Polyzos SA, Deretzi G, The gut-brain axis: interactions between Helicobacter pylori and enteric and central nervous systemsAnn Gastroenterol 2015; 28: 506
6. Kountouras J, Zavos C, Polyzos SA, Katsinelos P, Deretzi G, Association between cirrhosis and Helicobacter pylori-related brain pathologiesEur J Gastroenterol Hepatol 2015; 27: 183
7. Kountouras J, Gavalas E, Polyzos SA, Association between Helicobacter pylori burden and Alzheimer’s diseaseEur J Neurol 2014; 21: e100
8. Kocsis AK, Kiss ZF, Tiszlavicz J, Tiszlavicz Z, Mandi Y, Potential role of human beta-defensin 1 in Helicobacter pylori-induced gastritisScand J Gastroenterol 2009; 44: 289-295.
9. Kountouras J, Deretzi G, Gavalas E, A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disordersMed Hypotheses 2014; 82: 368-373.
10. Zhao D, Sun T, Zhang X, Role of CD14 promoter polymorphisms in Helicobacter pylori infection--related gastric carcinomaClin Cancer Res 2007; 13: 2362-2368.